Cronos Group Inc - Asset Resilience Ratio
Cronos Group Inc (CRON) has an Asset Resilience Ratio of 69.94% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CRON net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Cronos Group Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Cronos Group Inc.
Liquid Assets Composition Over Time
This chart breaks down Cronos Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Cronos Group Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$784.17 Million | 66.54% |
| Short-term Investments | CA$40.00 Million | 3.39% |
| Total Liquid Assets | CA$824.17 Million | 69.94% |
Asset Resilience Insights
- Very High Liquidity: Cronos Group Inc maintains exceptional liquid asset reserves at 69.94% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Cronos Group Inc Industry Peers by Asset Resilience Ratio
Compare Cronos Group Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Kamada
TA:KMDA |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 1.48% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 4.31% |
|
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723 |
Drug Manufacturers - Specialty & Generic | 1.01% |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL |
Drug Manufacturers - Specialty & Generic | 5.90% |
Annual Asset Resilience Ratio for Cronos Group Inc (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Cronos Group Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 73.63% | CA$858.80 Million ≈ $621.25 Million |
CA$1.17 Billion ≈ $843.69 Million |
-1.93pp |
| 2023-12-31 | 75.57% | CA$861.53 Million ≈ $623.22 Million |
CA$1.14 Billion ≈ $824.72 Million |
+3.21pp |
| 2022-12-31 | 72.36% | CA$877.72 Million ≈ $634.93 Million |
CA$1.21 Billion ≈ $877.47 Million |
+0.48pp |
| 2021-12-31 | 71.88% | CA$1.00 Billion ≈ $726.75 Million |
CA$1.40 Billion ≈ $1.01 Billion |
+4.90pp |
| 2020-12-31 | 66.98% | CA$1.29 Billion ≈ $933.01 Million |
CA$1.93 Billion ≈ $1.39 Billion |
-5.07pp |
| 2019-12-31 | 72.04% | CA$1.51 Billion ≈ $1.09 Billion |
CA$2.09 Billion ≈ $1.51 Billion |
+59.56pp |
| 2018-12-31 | 12.48% | CA$23.93 Million ≈ $17.31 Million |
CA$191.71 Million ≈ $138.68 Million |
+3.78pp |
| 2017-12-31 | 8.70% | CA$6.99 Million ≈ $5.06 Million |
CA$80.34 Million ≈ $58.12 Million |
+0.46pp |
| 2016-12-31 | 8.24% | CA$2.63 Million ≈ $1.90 Million |
CA$31.92 Million ≈ $23.09 Million |
-- |
About Cronos Group Inc
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.